当前位置:首页 - 行情中心 - 京新药业(002020) - 财务分析 - 资产负债表

京新药业

(002020)

  

流通市值:74.90亿  总市值:98.24亿
流通股本:6.56亿   总股本:8.61亿

资产负债表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
流动资产:
货币资金2,069,633,166.851,460,812,995.031,243,076,314.621,484,616,299.1
应收票据及应收账款536,414,979.08571,455,790.11497,021,499.95452,316,688.27
应收账款536,414,979.08571,455,790.11497,021,499.95452,316,688.27
应收款项融资37,934,673.7241,121,993.4844,316,269.5344,732,857.07
预付款项16,439,096.6413,333,192.8317,032,364.0915,353,630.41
其他应收款合计33,243,597.5228,140,459.9332,262,931.9640,385,769.81
存货649,915,856.83652,687,352.33677,514,674.34723,419,697.56
一年内到期的非流动资产184,978,380.3408,161,004.72--
其他流动资产24,844,559.0727,065,871.4440,744,483.7132,056,655.12
流动资产平衡项目0000
流动资产合计3,663,557,429.93,353,734,601.872,733,581,937.573,019,394,099.45
非流动资产:
长期股权投资62,516,225.6462,516,225.6480,029,097.7780,029,097.77
其他非流动金融资产549,787,684.58549,787,162.87514,582,771.61514,486,615
投资性房地产344,285,549.81347,153,989.83129,624,430.29130,867,127.73
固定资产2,188,089,740.61,775,344,840.681,295,760,305.471,320,035,826.66
在建工程146,744,635.25482,064,494.27753,186,139.07509,423,645.49
使用权资产39,431,550.9842,786,659.6145,654,722.1347,965,781.72
无形资产397,959,719.12401,264,048.22406,975,818.35411,113,179.7
商誉348,484,738.83348,484,738.83348,484,738.83348,484,738.83
长期待摊费用19,687,865.8421,201,94422,613,669.5921,623,494.75
递延所得税资产85,893,809.5580,983,213.1568,864,855.3462,137,088.36
其他非流动资产483,375,342.47521,234,988.191,220,754,533.721,095,246,235.34
非流动资产平衡项目0000
非流动资产合计4,666,256,862.674,632,822,305.294,886,531,082.174,541,412,831.35
资产平衡项目0000
资产总计8,329,814,292.577,986,556,907.167,620,113,019.747,560,806,930.8
流动负债:
短期借款332,000,000279,091,047.23359,317,574.31359,317,574.31
应付票据及应付账款1,041,915,828.22941,159,613.33779,953,211.55883,484,788.09
其中:应付票据354,489,891.68330,311,041.42392,163,362.35450,716,321.11
应付账款687,425,936.54610,848,571.91387,789,849.2432,768,466.98
预收款项000-
合同负债44,344,094.4853,346,482.547,359,516.844,817,314.04
应付职工薪酬147,579,852.41164,768,308.25115,013,901.27103,132,383.47
应交税费78,809,679.9687,922,712.6937,306,271.4438,781,045.54
其他应付款合计586,057,382.92532,346,962.04500,989,365.98506,437,869.07
一年内到期的非流动负债11,217,239.5511,860,183.3410,581,984.0310,949,942.18
其他流动负债4,703,791.874,263,307.15,926,476.35,590,529.2
流动负债平衡项目0000
流动负债合计2,246,627,869.412,074,758,616.481,856,448,301.681,952,511,445.9
非流动负债:
长期借款000-
租赁负债30,775,480.7731,227,710.5938,741,377.5238,817,092.65
预计负债2,849,499.373,202,705.171,941,247.111,941,247.11
递延收益264,816,876.7268,812,706.05278,192,741.13279,902,020.47
递延所得税负债70,692,729.2368,399,863.8558,527,078.3257,304,067.99
非流动负债平衡项目0000
非流动负债合计369,134,586.07371,642,985.66377,402,444.08377,964,428.22
负债平衡项目0000
负债合计2,615,762,455.482,446,401,602.142,233,850,745.762,330,475,874.12
所有者权益(或股东权益):
实收资本(或股本)861,029,140861,029,140861,029,140861,029,140
资本公积1,723,278,051.571,723,278,051.571,720,168,443.491,720,168,443.49
减:库存股000-
其他综合收益1,312,743.61,038,461.112,039,968.881,937,388.29
专项储备12,824,165.0412,824,165.049,929,635.259,938,051.79
盈余公积374,110,747.91374,110,747.91324,774,718.85324,774,718.85
未分配利润2,711,301,762.052,540,093,920.62,443,155,451.332,286,456,070.4
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计5,683,856,610.175,512,374,486.235,361,097,357.85,204,303,812.82
少数股东权益30,195,226.9227,780,818.7925,164,916.1826,027,243.86
股东权益平衡项目0000
股东权益合计5,714,051,837.095,540,155,305.025,386,262,273.985,230,331,056.68
负债和股东权益合计8,329,814,292.577,986,556,907.167,620,113,019.747,560,806,930.8
公告日期2024-04-242024-03-302023-10-272023-08-15
审计意见(境内)标准无保留意见
TOP↑